Results 71 to 80 of about 4,485 (161)

The Effect of Insulin Detemir on the Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus

open access: yes, 2008
Aim: Since there is limited number of studies in medical literature regarding the efficiency of in-sulin detemir, decrease in number of night hypoglycemia, weight changes and the improvement the lipid profile in pediatric and adolescent age group, we ...
Ece Böber   +4 more
core  

The Effect of Basal Analog Insulin on the Glycemic Variability in Type 2 Diabetics

open access: yesEndocrinology Research and Practice, 2014
Purpose: The aim of this study was to investigate the effect of insulin detemir and glargine on glycemic variability as determined by capillary blood glucose measurements in Type 2 diabetics treated with oral antidiabetic drugs.
Soner Cander   +4 more
doaj   +1 more source

Effect of Insulin Detemir (Levemir®) on Risk of Hypoglycaemia and Glycaemic Parameters: Experience from Real Life Practice in Indonesian Patients with Diabetes Mellitus

open access: yesJournal of the ASEAN Federation of Endocrine Societies
Objective. To evaluate the safety and efficacy of insulin detemir in patients with diabetes mellitus in Indonesia.   Methods. This was a multi-centre, prospective, 12-week observational study in patients with diabetes mellitus conducted in Indonesia. 
Pradana Soewondo, Anand Jain
doaj   +1 more source

Insulin detemir (Levemir)

open access: yes, 2005
peer reviewedInsulin detemir (Levemir) is a soluble long acting human insulin analogue acylated with a 14-carbon fatty acid. The fatty acid modification allows insulin detemir to reversibly bind to albumin, thereby providing slow absorption and a ...
Scheen, André   +3 more
core  

Metabolic parameters and beta activity during infusion of human insulin, insulin detemir and saline in 10 overweight individuals.

open access: yes, 2013
A: Plasma human insulin and total serum insulin detemir concentrations. Similar profiles of plasma/serum levels (Mean±SE) of human insulin and insulin detemir were achieved with both insulins.
Niels Birbaumer (36361)   +9 more
core   +1 more source

Long-acting insulin allergy in a diabetic child

open access: yesInternational Journal of Immunopathology and Pharmacology, 2017
Insulin allergy has been uncommon since the introduction of human recombinant insulin preparations; the prevalence is 2.4%. Insulin injection could elicit immediate reactions, which are usually induced by an IgE-mediated mechanism, within the first hour ...
Carla Mastrorilli   +5 more
doaj   +1 more source

Porównanie insuliny detemir i insuliny glargina stosowanych u pacjentów z cukrzycą typu 1 poddawanych intensywnej insulinoterapii [PDF]

open access: yes, 2007
BACKGROUND. To compare glycaemic control and risk of hypoglycaemia of twice-daily insulin detemir with once-daily insulin glargine in subjects with type 1 diabetes. MATERIAL AND METHODS. In this 26-week, multicentre, open-label, parallel-group trial, 320
Robertson, L.I.   +6 more
core  

Relationship of Insulin Dose, A1c Lowering, and Weight in Type 2 Diabetes: Comparing Insulin Glargine and Insulin Detemir

open access: yes, 2010
Background: A pooled analysis of randomized controlled trials of individuals with type 2 diabetes mellitus (T2DM) was conducted to compare dosing and impact of two basal insulin analogs, insulin glargine (glargine) and insulin detemir (detemir), on ...
Karim Admane   +7 more
core   +1 more source

Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs

open access: yesDrug, Healthcare and Patient Safety, 2010
Kitty Poon, Allen B KingDiabetes Care Center, Salinas, CA, USAAbstract: Diabetes mellitus is a growing public health concern in the US and worldwide. Insulin therapy is the cornerstone of diabetes therapy, and the use of basal insulins will increase as ...
Kitty Poon, Allen B King
doaj  

Insulin detemir and basal insulin therapy.

open access: yes, 2007
With the introduction of insulin detemir (Levemir [Novo Nordisk A/S, Bagsvaerd, Denmark]), a long-acting basal insulin analog, it is an opportune moment to reevaluate the use of basal insulin therapy and consider current treatment strategies, including ...
Russell-Jones, DL
core  

Home - About - Disclaimer - Privacy